<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01919372</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-MTP-2012-74</org_study_id>
    <nct_id>NCT01919372</nct_id>
  </id_info>
  <brief_title>Individualized Telemedical Assistance for Lifestyle Modification in the Treatment of Obesity and Cardiometabolic Risk Prevention</brief_title>
  <acronym>PREDIRCAM 2</acronym>
  <official_title>Intensificación y monitorización telemática Personalizada de la modificación Del Estilo de Vida en el Tratamiento de la Obesidad y la prevención Del Riesgo cardiometabólico</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Grupo de Bioingenieria y Telemedicina -ETSI Telecomunicacion. Universidad Politecnica de Madrid</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Spanish Clinical Research Network - CAIBER</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is based on the contribution that could offer a technological system for a
      continuous monitoring, individualized treatment of obesity and prevention of cardiometabolic
      complications in high risk population.

      The main objective of PREDIRCAM study is to evaluate the benefits obtained with the use in
      high cardiometabolic risk individuals of a telemedical platform integrating applications for
      monitoring and providing recommendations to improve lifestyle habits (diet and physical
      activity) in a healthier way.

      The study population are obese subjects (type I or II) aged between 25 and 65 years with a 12
      month follow-up. In this population it will be analysed the cost-effectiveness of a telemedic
      assistance with a technological system and its ability to modify lifestyle habits, reduce
      weight and cardiovascular risk associated parameters.

      Previously to the clinical implementation, a pilot study for testing the telemedical system
      will be made. Efficacy and security variables will be evaluated along the study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 29, 2015</start_date>
  <completion_date type="Actual">January 25, 2018</completion_date>
  <primary_completion_date type="Actual">December 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiometabolic risk prevention</measure>
    <time_frame>1 year</time_frame>
    <description>We will measure different parameters related to cardiovascular risk, such as adiponectine, tumour necrosis factor, Homeostasis Model Assessment, etc.at the beginning and at the end of the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">183</enrollment>
  <condition>Obesity Type I and II</condition>
  <arm_group>
    <arm_group_label>Conventional assistance</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual treatment of obesity in terms of monitoring lifestyle habits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemedic assistance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>telemedical assistance with a technological system to provide a continuous monitoring of lifestyle habits and individualized treatment of obesity</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemedic assistance with a technological system</intervention_name>
    <arm_group_label>Telemedic assistance</arm_group_label>
    <other_name>PREDIRCAM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <arm_group_label>Conventional assistance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Preclinical Phase:

        1. People over 18 years with or without obesity and with ability for technology management

        Clinical Phase:

          1. People between 18 and 65 years.

          2. Obesity defined as a body mass index (BMI) greater than or equal to 30 kg/m2:

               1. Grade I or II without sleep apnea syndrome and ischemic heart disease

               2. Absence of metabolic processes (dyslipidemia) or associated hypertension
                  requiring drug treatment at the time of inclusion in the study.

          3. People with ability for technology management

        Exclusion Criteria:

        Preclinical Phase:

        1. Serious illness and / or disabling

        Clinical Phase:

          1. Diabetes defining according to American Diabetes Association (ADA) criteria.

          2. Subjects with moderate to severe active disease at the time of inclusion in the study
             protocol

          3. Impaired glucose metabolism related diseases associated with diabetes mellitus or
             drugs interfering carbohydrate metabolism.

          4. Cardiovascular disease

          5. Dyslipidemia or hypertension requiring drug treatment.

          6. Alcohol consumption

          7. Pregnancy

          8. Serious illness and / or disabling
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2013</study_first_submitted>
  <study_first_submitted_qc>August 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2013</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

